XML 57 R39.htm IDEA: XBRL DOCUMENT v3.23.2
SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
 12 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Weighted Average Number of Shares Outstanding, Basic (in Shares)   52,576,258 49,991,631
Net Income (Loss) Attributable to Parent   $ (11,506,000) $ (15,016,000)
Line of Credit Facility, Current Borrowing Capacity $ 12,000,000    
Stock Issued During Period, Shares, New Issues (in Shares) 10,000,000    
Stock Issued During Period, Value, New Issues $ 3,000,000 103,000 4,145,000
Accounts Receivable, after Allowance for Credit Loss   107,000 125,000
Accounts Receivable, Allowance for Credit Loss   17,000 93,000
Cash and Cash Equivalents, at Carrying Value   3,196,000 10,460,000
Inventory, Net   2,651,000 3,548,000
Research and Development Expense   3,461,000 2,330,000
Clinical Trial Inventory [Member]      
SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Inventory, Net   $ 407,000 $ 0